Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» triple-negative breast cancer
triple-negative breast cancer
AstraZeneca’s Truqap flops in phase III triple-negative breast cancer trial
BioSpace
Tue, 06/18/24 - 11:46 am
AstraZeneca
Truqap
triple-negative breast cancer
Hummingbird Bioscience Announces HMBD-002 Trials in Progress Poster at ASCO Annual Meeting 2023
BioSpace
Tue, 05/30/23 - 09:47 am
Hummingbird Biosciences
HMBD-002
cliincal trials
ASCO 2023
triple-negative breast cancer
non-small cell lung cancer
Immunomedics raises $459M as Trodelvy breast cancer launch kicks off amid COVID-19
Fierce Pharma
Mon, 05/11/20 - 11:35 pm
Immunomedics
drug launches
Trodelvy
triple-negative breast cancer
pandemic
COVID-19
Back to the drawing board for triple-negative breast cancer targets, researchers propose new combo approach
Endpoints
Wed, 03/11/20 - 04:16 pm
triple-negative breast cancer
Vanderbilt
R&D
SABCS: Merck's Keytruda notches win in triple-negative breast cancer as Roche's Tecentriq falls short
Fierce Pharma
Thu, 12/12/19 - 11:12 am
Merck
Ketyruda
Roche
Tecentriq
immuno-oncology
SABCS
triple-negative breast cancer
UK gets early access to Roche’s breast cancer immunotherapy
Pharmaforum
Sat, 03/16/19 - 12:18 pm
Roche
Tecentriq
Celgene
Abraxane
UK
triple-negative breast cancer
Merck drug shrank tumors in some breast cancer patients in trial
Marketwatch
Wed, 12/10/14 - 09:44 am
Merck
Keytruda
triple-negative breast cancer
AbbVie Advances with Cancer Candidate
Yahoo/Zacks.com
Thu, 01/16/14 - 09:31 am
AbbVie
veliparib
triple-negative breast cancer
AbbVie drug shows promise against difficult type of breast cancer
Reuters
Fri, 12/13/13 - 10:31 am
AbbVie
veliparib
triple-negative breast cancer
Corcept files IND with FDA for Phase I oncology study
The Fly on the Wall
Thu, 12/12/13 - 11:04 am
Corcept Therapeutics
FDA
mifepristone
triple-negative breast cancer
Aveo's Future Depends on Triple-Negative Breast Cancer
TheStreet.com
Thu, 06/6/13 - 10:35 am
Aveo Oncology
triple-negative breast cancer
tivozanib
EntreMed announces initiation of phase 2 trial in triple-negative breast cancer
Yahoo/Fly on the Wall
Wed, 07/25/12 - 09:33 am
EntreMed
triple-negative breast cancer
breast cancer
ENMD-2076